ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - EBR:IBAB - BE0003766806 - Common Stock
10.74 EUR
-0.18 (-1.65%)
Taking everything into account, IBAB scores 4 out of 10 in our fundamental rating. IBAB was compared to 60 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of IBAB while its profitability can be described as average. IBAB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBAB was profitable.
In the past year IBAB had a positive cash flow from operations.
IBAB had positive earnings in 4 of the past 5 years.
In multiple years IBAB reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.71%, IBAB is in line with its industry, outperforming 46.67% of the companies in the same industry.
IBAB's Return On Equity of 14.29% is fine compared to the rest of the industry. IBAB outperforms 78.33% of its industry peers.
IBAB has a better Return On Invested Capital (15.54%) than 95.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IBAB is below the industry average of 9.00%.
The last Return On Invested Capital (15.54%) for IBAB is above the 3 year average (6.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB has a Profit Margin (2.85%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IBAB has declined.
With a Operating Margin value of 6.48%, IBAB perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
IBAB's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 31.21%, IBAB is not doing good in the industry: 81.67% of the companies in the same industry are doing better.
IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBAB is creating value.
IBAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IBAB has less shares outstanding
Compared to 1 year ago, IBAB has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.60, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
IBAB has a Altman-Z score of 1.60. This is in the lower half of the industry: IBAB underperforms 63.33% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
IBAB has a better Debt to Equity ratio (0.23) than 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.6 |
ROIC/WACC2.15
WACC7.21%
2.3 Liquidity
A Current Ratio of 0.94 indicates that IBAB may have some problems paying its short term obligations.
IBAB's Current ratio of 0.94 is on the low side compared to the rest of the industry. IBAB is outperformed by 83.33% of its industry peers.
A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
The Quick ratio of IBAB (0.62) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.86%, which is quite impressive.
IBAB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.99% yearly.
Looking at the last year, IBAB shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.01% yearly.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
IBAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.96% yearly.
IBAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.63% yearly.
EPS Next Y171.48%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y57.96%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.84, which indicates a rather expensive current valuation of IBAB.
IBAB's Price/Earnings ratio is rather cheap when compared to the industry. IBAB is cheaper than 81.67% of the companies in the same industry.
IBAB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.51.
A Price/Forward Earnings ratio of 9.89 indicates a reasonable valuation of IBAB.
Based on the Price/Forward Earnings ratio, IBAB is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of IBAB to the average of the S&P500 Index (22.53), we can say IBAB is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.84 | ||
| Fwd PE | 9.89 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaper than 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.49 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBAB's earnings are expected to grow with 69.87% in the coming years.
PEG (NY)0.11
PEG (5Y)4.73
EPS Next 2Y112.13%
EPS Next 3Y69.87%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.54%.
IBAB's Dividend Yield is a higher than the industry average which is at 2.13.
Compared to the average S&P500 Dividend Yield of 2.38, IBAB is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.54% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EBR:IBAB (11/3/2025, 7:00:00 PM)
10.74
-0.18 (-1.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap325.21M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.96 (39.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.54% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-29.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.84 | ||
| Fwd PE | 9.89 | ||
| P/S | 0.55 | ||
| P/FCF | N/A | ||
| P/OCF | 116.81 | ||
| P/B | 2.73 | ||
| P/tB | 3.45 | ||
| EV/EBITDA | 7.49 |
EPS(TTM)0.57
EY5.31%
EPS(NY)1.09
Fwd EY10.11%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.86%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.11
PEG (5Y)4.73
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.6 |
F-Score7
WACC7.21%
ROIC/WACC2.15
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y171.48%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y57.96%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year213.8%
EBIT Next 3Y66.86%
EBIT Next 5Y52.17%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 18.84 and the Price/Book (PB) ratio is 2.73.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 171.48% in the next year.